SEKISUI Diagnostics
Scott Bickert has extensive work experience in various roles and companies. Scott started their career at Cellular One Rochester in 1996 as a Sales Executive. Scott then joined Arrow International in 1999 as a Regional Sales Specialist. In 2004, they moved to Diagnostic Chemicals Ltd as a Regional Sales Executive. In 2007, they joined SEKISUI Diagnostics as a Senior Sales Executive, where they were responsible for selling Clinical Chemistry reagents to independent, hospital, and reference laboratories in the Eastern US. Scott later served as a Senior Strategic Account Manager and Associate Director of Global Strategic Accounts at SEKISUI Diagnostics. Currently, they hold the position of Director of Global Strategic Accounts at SEKISUI Diagnostics, a role they have been in since December 2022.
Scott Bickert earned a Bachelor of Arts (BA) degree in Computer Science from the State University of New York at Oswego. Scott attended the university from 1985 to 1990.
This person is not in any offices
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals